Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CYTOKINETICS INC | Director | Common Stock | 17.6K | $918K | $52.07 | Jun 10, 2024 | Direct |
VERACYTE, INC. | Director | Common Stock | 34.6K | $712K | $20.59 | Jun 13, 2024 | Direct |
Intellia Therapeutics, Inc. | Director | Common Stock | 19.7K | $651K | $32.99 | Jun 12, 2024 | Direct |
ARDELYX, INC. | Director | Stock Option (Right to Buy) | 40.2K | $93.4K | $2.32 | Jun 14, 2024 | Direct |
Intellia Therapeutics, Inc. | Director | Stock Option (right to buy) | 11.5K | Jun 12, 2024 | Direct | ||
CYTOKINETICS INC | Director | Non-Qualified Stock Option (Right to Buy) | 3.64K | May 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARDX | ARDELYX, INC. | Jun 14, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
VCYT | VERACYTE, INC. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
NTLA | Intellia Therapeutics, Inc. | Jun 12, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
VCYT | VERACYTE, INC. | Jun 10, 2024 | 1 | -$78.6K | 4 | Jun 11, 2024 | Director |
CYTK | CYTOKINETICS INC | Jun 10, 2024 | 1 | -$104K | 4 | Jun 10, 2024 | Director |
VCYT | VERACYTE, INC. | May 28, 2024 | 1 | -$32.3K | 4 | May 30, 2024 | Director |
CYTK | CYTOKINETICS INC | May 15, 2024 | 2 | $0 | 4 | May 16, 2024 | Director |
NTLA | Intellia Therapeutics, Inc. | Oct 31, 2023 | 1 | -$6.33K | 4 | Nov 2, 2023 | Director |
NTLA | Intellia Therapeutics, Inc. | Jul 31, 2023 | 1 | -$11.2K | 4 | Aug 2, 2023 | Director |
CYTK | CYTOKINETICS INC | Jul 7, 2023 | 1 | -$68.2K | 4 | Jul 7, 2023 | Director |
NTLA | Intellia Therapeutics, Inc. | Jul 6, 2023 | 1 | -$73.4K | 4 | Jul 10, 2023 | Director |
VCYT | VERACYTE, INC. | Jun 16, 2023 | 2 | -$156K | 4 | Jun 21, 2023 | Director |
ARDX | ARDELYX, INC. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
NTLA | Intellia Therapeutics, Inc. | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
VCYT | VERACYTE, INC. | Jun 9, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
VCYT | VERACYTE, INC. | May 30, 2023 | 1 | -$39.9K | 4 | Jun 1, 2023 | Director |
CYTK | CYTOKINETICS INC | May 10, 2023 | 2 | $0 | 4 | May 18, 2023 | Director |
CYTK | CYTOKINETICS INC | Oct 3, 2022 | 1 | $11.2K | 4 | Oct 5, 2022 | Director |
CYTK | CYTOKINETICS INC | Jul 1, 2022 | 1 | $11.2K | 4 | Jul 12, 2022 | Director |
VCYT | VERACYTE, INC. | Jun 16, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
ARDX | ARDELYX, INC. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
NTLA | Intellia Therapeutics, Inc. | Jun 14, 2022 | 2 | $0 | 4 | Jun 16, 2022 | Director |
CYTK | CYTOKINETICS INC | May 10, 2022 | 2 | $0 | 4 | May 11, 2022 | Director |
NTLA | Intellia Therapeutics, Inc. | Apr 28, 2022 | 2 | $0 | 4 | May 2, 2022 | Director |
NTLA | Intellia Therapeutics, Inc. | Apr 28, 2022 | 0 | $0 | 3 | May 2, 2022 | Director |
CYTK | CYTOKINETICS INC | Apr 1, 2022 | 1 | $11.2K | 4 | Apr 1, 2022 | Director |
CYTK | CYTOKINETICS INC | Jan 3, 2022 | 1 | $11.2K | 4 | Jan 4, 2022 | Director |
CYTK | CYTOKINETICS INC | May 12, 2021 | 2 | $0 | 4 | May 13, 2021 | Director |